Aerpio launches mid-stage study of razuprotafib in glaucoma Seeking Alpha, 24 Jun 2020 Enrollment is underwa y in a 195-subject Phase 2 clinical trial evaluating Aerpio Pharmaceuticals' ( OTC:ARPO ) razuprotafib…